skip to the content

Precise VEGF inhibition by Avastin limits toxicity

MoA influences safety profile

  • The side effects of biological agents are directly related to their MoA and specificity for their target, as discussed in the section of this website called ‘Approaches to VEGF inhibition’.
 
  • This section looks at the safety profile of Avastin and how this is directly related to inhibition of the VEGF pathway.
 

The safety profile of Avastin
The safety profile of Avastin does not overlap with those of concomitant therapies
Summary: precise VEGF inhibition limits toxicity
References: precise VEGF inhibition limits toxicity